142 related articles for article (PubMed ID: 21641677)
1. Clinical differentiation of acute cutaneous graft-versus-host disease from drug hypersensitivity reactions.
Byun HJ; Yang JI; Kim BK; Cho KH
J Am Acad Dermatol; 2011 Oct; 65(4):726-732. PubMed ID: 21641677
[TBL] [Abstract][Full Text] [Related]
2. A clinical and histological comparison between acute cutaneous graft-versus-host disease and other maculopapular eruptions following hematopoietic stem cell transplantation: a retrospective cohort.
Chanprapaph K; Leerunyakul K; Niparuck P; Rutnin S
Int J Dermatol; 2021 Jan; 60(1):60-69. PubMed ID: 32989780
[TBL] [Abstract][Full Text] [Related]
3. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
[TBL] [Abstract][Full Text] [Related]
4. Acute cutaneous graft-vs.-host disease compared to drug hypersensitivity reaction with vacuolar interface changes: a blinded study of microscopic and immunohistochemical features.
Lehman JS; Gibson LE; el-Azhary RA; Chavan RN; Hashmi SK; Lohse CM; Flotte TJ
J Cutan Pathol; 2015 Jan; 42(1):39-45. PubMed ID: 25393781
[TBL] [Abstract][Full Text] [Related]
5. [Skin manifestations of graft-versus-host reaction following bone marrow transplantation].
Itin PH; Lautenschlager S; Orth B; Rufli T; Gratwohl A
Schweiz Med Wochenschr; 1996 Mar; 126(9):339-47. PubMed ID: 8701251
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of eosinophils in acute graft-versus-host disease compared with drug hypersensitivity reactions.
Weaver J; Bergfeld WF
Am J Dermatopathol; 2010 Feb; 32(1):31-4. PubMed ID: 19730082
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous manifestations of chronic graft-versus-host disease.
Andrews ML; Robertson I; Weedon D
Australas J Dermatol; 1997 May; 38(2):53-62; quiz 63-4. PubMed ID: 9159958
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous graft-versus-host disease].
Karrer S
Hautarzt; 2003 May; 54(5):465-80; quiz 481-2. PubMed ID: 12833893
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous manifestations of graft versus host disease in a population of pediatric and young adults patients].
Martino C; Calvano R; Boggio P; Scacchi MF; Sojo M; Carbajosa A; Makiya M; Giachetti A
Arch Argent Pediatr; 2020 Oct; 118(5):e468-e475. PubMed ID: 32924403
[TBL] [Abstract][Full Text] [Related]
10. Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.
Brüggen MC; Petzelbauer P; Greinix H; Contassot E; Jankovic D; French L; Socié G; Rabitsch W; Kuzmina Z; Kalhs P; Knobler R; Stingl G; Stary G
J Invest Dermatol; 2015 Apr; 135(4):999-1006. PubMed ID: 25405322
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.
Goldberg J; Jacobsohn DA; Zahurak ML; Vogelsang GB
Biol Blood Marrow Transplant; 2005 Feb; 11(2):101-7. PubMed ID: 15682070
[TBL] [Abstract][Full Text] [Related]
12. Atopic dermatitis-like presentation of graft-versus-host disease: a novel form of chronic cutaneous graft-versus-host disease.
Wei J; Zhang Y; Xu H; Jin J; Zhang J
J Am Acad Dermatol; 2013 Jul; 69(1):34-9. PubMed ID: 23375455
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions.
Fujii H; Hiketa T; Matsumoto Y; Ohashi M; Miyamura Y; Tanimoto M; Morishima Y; Saito H; Horibe K; Shibata Y
Bone Marrow Transplant; 1992 Oct; 10(4):331-5. PubMed ID: 1422488
[TBL] [Abstract][Full Text] [Related]
14. Gloves and socks syndrome after bone marrow transplantation.
Troeger A; Laws HJ
Br J Haematol; 2008 Mar; 140(5):478. PubMed ID: 18053069
[No Abstract] [Full Text] [Related]
15. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
16. Acute follicular graft-vs-host reaction. A distinct clinicopathologic presentation.
Friedman KJ; LeBoit PE; Farmer ER
Arch Dermatol; 1988 May; 124(5):688-91. PubMed ID: 3284466
[TBL] [Abstract][Full Text] [Related]
17. The role of skin biopsies in bone marrow transplant recipients.
Hepburn NC; McLaren KM; Turner ML; Beveridge GW
Q J Med; 1993 Nov; 86(11):715-7. PubMed ID: 8265771
[TBL] [Abstract][Full Text] [Related]
18. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
[TBL] [Abstract][Full Text] [Related]
20. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
Marra DE; McKee PH; Nghiem P
J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
